Apr 2, 2026 12:00PM

Dec 29, 2025 12:03PM

Aug 29, 2025 04:30PM

Jul 10, 2025 07:43AM

Aug 29, 2024 04:30PM

Aug 31, 2023 09:00AM

Sep 7, 2021 04:30PM Ultragenyx to Present at Morgan Stanley Healthcare Conference

Sep 7, 2021 04:30PM

Dec 16, 2020 07:22AM

Sep 3, 2020 08:31AM

Sep 3, 2020 08:31AM

Nov 6, 2019 06:37AM

Aug 30, 2019 08:30AM

Aug 30, 2019 08:30AM Ultragenyx to Present at Upcoming Investor Conferences

Jun 17, 2019 09:06AM

Mar 27, 2019 07:00AM

Oct 29, 2018 09:21AM

Sep 10, 2018 07:37AM

Aug 30, 2018 08:30AM

Aug 7, 2018 07:14AM

Apr 13, 2018 07:41AM Ultragenyx Pharma (RARE) PT Lowered to $55 at Morgan Stanley

Feb 21, 2018 07:47AM

Jan 23, 2018 09:23AM

Dec 1, 2017 07:46AM

Oct 6, 2017 09:06AM

Sep 6, 2017 08:30AM

Aug 23, 2017 08:42AM

May 8, 2017 09:08AM Ultragenyx Pharma (RARE) PT Lowered to $79 at Morgan Stanley

Apr 19, 2017 09:27AM

Nov 14, 2016 10:21AM

Jul 15, 2016 09:30AM

Jul 27, 2015 09:35AM

Jul 27, 2015 07:04AM

Jul 21, 2015 04:30PM

Jul 21, 2015 04:30PM Ultragenyx Announces Closing of Public Offering of Common Stock and Exercise of Underwriters' Option to Purchase Additional Shares

Jul 16, 2015 06:43AM

Jul 15, 2015 09:15PM

Jul 15, 2015 09:15PM

Jul 14, 2015 04:03PM

Jul 14, 2015 04:02PM

Jul 14, 2015 04:02PM

Feb 17, 2015 09:00AM Ultragenyx Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

Feb 5, 2015 07:15AM

Feb 3, 2015 04:40PM

Jul 14, 2014 01:32PM

Jul 9, 2014 06:17AM

Jul 7, 2014 04:30PM

Feb 25, 2014 12:20PM

Feb 25, 2014 08:08AM Morgan Stanley Starts Ultragenyx Pharma (RARE) at Overweight

Jan 31, 2014 10:25AM

219,876 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All